According to Publisher, the Global Vascular Stents Market is accounted for $8.21 billion in 2015 and is expected to reach $11.6 billion by 2022 growing at a CAGR of 5.18% from 2015 to 2022. Growing recognition for vascular stents and increasing occurrence of cardiovascular diseases are the major factors driving the market growth. Moreover, growing number of aging population, increasing occurrence in peripheral diseases and improving new R&D devices and technologies are bolstering the growth of the market. However, huge capital for vascular stents and availability of different therapies are the major drawbacks in this market. On the other hand, increasing fondness for bioabsorbable stents will boost this market growth over the forecast period. Growing risk from substitutes and extreme competition are the major challenges involved.
Coronary Stents segment accounted for the largest share in this market due to growing number of aging population and accessibility of advanced treatments in this market. North America accounted for the largest market share during the forecast period owing to increased developments in technologies and important expenses of power in large segments. Moreover, Asia Pacific is the fastest promising market for global vascular stents market over the forecast period due to reduced cost of surgeries for healthcare treatments.
For more information http://www.reportsweb.com/vascular-stents-global-market-outlook-2015-2022
Some of the key players in this market include Medtronic, Inc., Biosensors International Ltd., Abbott Laboratories, InnoCore Technologies BV, Stentys SA, MIV Therapeutics Inc., MicroPort Scientific Corp., X-Cell Medical Inc., InnoCore Technologies BV, Reva Medical Inc., Translumina GmbH, Boston Scientific Corporation, Goodman Co. Ltd., C.R.Bard Inc. and W.L. Gore & Associates.
-Carotid Artery Stents
-Fem-pop Artery Stents
-Renal Artery Stents
-Iliac Artery Stents
-Peripheral vascular stents
-Absorbable Magnesium Alloys
-Standard polymeric stents
-Biodegradable polymeric stents
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001322768/sample
10 Company Profiling
10.1 Medtronic, Inc.
10.2 Biosensors International Ltd.
10.3 Abbott Laboratories
10.4 InnoCore Technologies BV
10.5 Stentys SA
10.6 MIV Therapeutics Inc.
10.7 MicroPort Scientific Corp.
10.8 X-Cell Medical Inc.
10.9 InnoCore Technologies BV
10.10 Reva Medical Inc.
10.11 Translumina GmbH
10.12 Boston Scientific Corporation
10.13 Goodman Co. Ltd.
10.14 C.R.Bard Inc.
10.15 W.L. Gore & Associates
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001322768/buying